NCT01735643 Lifestyle Intervention With an Interactive Video Game for Type 2 Diabetes Patients Status COMPLETED Phase EARLY_PHASE1
NCT01734512 PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children Status COMPLETED Phase PHASE2
NCT01732107 Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression Status TERMINATED Phase PHASE2
NCT01731990 Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease Status TERMINATED Phase PHASE2
NCT01730768 A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients Status COMPLETED Phase PHASE2
NCT01730248 A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis Status TERMINATED Phase PHASE1
NCT01727141 A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation. Status COMPLETED Phase PHASE3
NCT01727128 Pharmacokinetic Study of BKM120 in Subjects With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT01727024 Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients Status COMPLETED Phase PHASE4
NCT01724138 An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old Status WITHDRAWN Phase PHASE4
NCT01723072 Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy Status COMPLETED Phase PHASE3
NCT01717898 A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01716754 Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma Status COMPLETED Phase PHASE2
NCT01716416 Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) Status COMPLETED Phase PHASE1
NCT01715311 Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control Status WITHDRAWN Phase PHASE4
NCT01713946 A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures Status COMPLETED Phase PHASE3
NCT01712516 A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation Status COMPLETED Phase PHASE3
NCT01711606 EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes Status TERMINATED Phase N/A